Dalton, Greiner, Hartman, Maher & Co’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-24,378
Closed -$2.23M 167
2020
Q2
$2.23M Sell
24,378
-37,532
-61% -$3.39M 0.22% 139
2020
Q1
$4.88M Sell
61,910
-35,640
-37% -$2.97M 0.51% 76
2019
Q4
$8.47M Sell
97,550
-8,412
-8% -$705K 0.58% 73
2019
Q3
$8.87M Buy
105,962
+76,114
+255% +$6.47M 0.61% 64
2019
Q2
$2.51M Sell
29,848
-1,072
-3% -$84.4K 0.21% 122
2019
Q1
$2.47M Sell
30,920
-17,384
-36% -$1.29M 0.21% 119
2018
Q4
$3.49M Sell
48,304
-182,855
-79% -$12.9M 0.26% 88
2018
Q3
$17M Sell
231,159
-16,512
-7% -$1.08M 0.85% 53
2018
Q2
$15.1M Buy
247,671
+160,289
+183% +$9.72M 0.77% 61
2018
Q1
$5.24M Sell
87,382
-209,938
-71% -$12.6M 0.35% 66
2017
Q4
$17M Sell
297,320
-37,551
-11% -$2.08M 0.89% 55
2017
Q3
$17.9M Sell
334,871
-5,758
-2% -$289K 1% 43
2017
Q2
$16.6M Sell
340,629
-5,770
-2% -$261K 0.96% 44
2017
Q1
$15.4M Buy
346,399
+116,542
+51% +$5.04M 0.88% 57
2016
Q4
$8.83M Sell
229,857
-7,952
-3% -$315K 0.52% 91
2016
Q3
$10.1M Sell
237,809
-56,574
-19% -$2.42M 0.65% 87
2016
Q2
$11.6M Sell
294,383
-57,090
-16% -$2.27M 0.72% 78
2016
Q1
$14.7M Sell
351,473
-109,865
-24% -$4.35M 0.91% 50
2015
Q4
$20.7M Buy
461,338
+28,164
+7% +$1.24M 1.19% 24
2015
Q3
$17.4M Sell
433,174
-72,484
-14% -$3.42M 0.98% 35
2015
Q2
$24.8M Sell
505,658
-27,272
-5% -$1.31M 1.29% 18
2015
Q1
$24.7M Buy
532,930
+23,290
+5% +$1.07M 1.39% 22
2014
Q4
$22.9M Sell
509,640
-44,718
-8% -$1.95M 1.27% 31
2014
Q3
$23.1M Sell
554,358
-214,910
-28% -$9.09M 1.31% 28
2014
Q2
$31.5M Buy
769,268
+38,532
+5% +$1.51M 1.65% 13
2014
Q1
$28.1M Buy
+730,736
New +$28.2M 1.63% 12

Other funds holding ABT

Dalton, Greiner, Hartman, Maher & Co's ABT Position: Q3 2020 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of Abbott (ABT) in Q3 2020, closing a stake of 24,378 shares — an estimated $2.23M sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in ABT in Q1 2014 and held it in 26 quarters. The position peaked at $31.5M in Q2 2014. 2,306 funds tracked by Wall St. Rank hold ABT as of Q3 2020.

  • Dalton, Greiner, Hartman, Maher & Co reported no remaining Abbott position as of Q3 2020 after selling out during the quarter.
  • Dalton, Greiner, Hartman, Maher & Co sold 24,378 Abbott shares in Q3 2020, an estimated $2.23M.
  • Dalton, Greiner, Hartman, Maher & Co first reported a position in Abbott in Q1 2014 and held it in 26 quarters.
  • Dalton, Greiner, Hartman, Maher & Co's Abbott position peaked at $31.5M in Q2 2014.
  • 2,306 funds tracked by Wall St. Rank held Abbott as of Q3 2020.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q3 2020, filed 9 Oct 2020.